Long-term survival of HIV-infected children receiving antiretroviral therapy in Thailand: A 5-year observational cohort study

Clinical Infectious Diseases

Volumn 51, Issue 12, 2010, Pages 1449-1457

  Collins, Intira J ^a,c,d,j   Jourdain, Gonzague ^a,c,d   Hansudewechakul, Rawiwan ^f   Kanjanavanit, Suparat ^e   Hongsiriwon, Suchat ^g   Ngampiyasakul, Chaiwat ^h   Sriminiphant, Somboon ⁱ   Technakunakorn, Pornchai ⁱ   Ngo Giang Huong, Nicole ^a,c,d   Duong, Trinh ^j   Le Coeur, Sophie ^a,b,c,d   Jaffar, Shabbar ^j   Lallemant, Marc ^a,c,d  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b LIP6   (France)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d CHIANG MAI UNIVERSITY   (Thailand)

^e Nakornping Provincial Hospital   (Thailand)

^f CHIANGRAI PRACHANUKROH HOSPITAL   (Thailand)

^g CHONBURI HOSPITAL   (Thailand)

^h Prappoklao Hospital   (Thailand)

ⁱ Phayao Provincial Hospital   (Thailand)

^j LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; DIDANOSINE; EFAVIRENZ; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ARTICLE; CD4 LYMPHOCYTE PERCENTAGE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK INFANT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SURVIVAL TIME; THAILAND;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THAILAND; TIME FACTORS;

EID: 78649827213     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/657401     Document Type: Article

References (43)

1. WHO/UNAIDS. Towards Universal Access: Scaling up priority HIV/ AIDS interventions in the health sector, Progress Report. 2009. http:// www.who.int/hiv/pub/2009progressreport/en/. Accessed 10 February 2010.
2. Sanne IM, Westreich D, Macphail AP, Rubel D, Majuba P, Van Rie A. Long term outcomes of antiretroviral therapy in a large HIV/AIDS care clinic in urban South Africa: a prospective cohort study. J Int AIDS Soc 2009; 12(1):38.
3. Boulle A, Van Cutsem G, Hilderbrand K, et al. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS 2010; 24(4):563-572.
4. UNAIDS/WHO/UNICEF. Report fromthe Consultative Meeting on Data Collection and Estimation Methods Related to HIV Infection in Infants and Children. 8-10 July 2008. New York.
5. Sutcliffe CG, van Dijk JH, Bolton C, Persaud D, Moss WJ. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis 2008; 8(8):477-489.
6. Puthanakit T, Aurpibul L, Oberdorfer P, et al. Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy. Clin Infect Dis 2007; 44(4):599-604. (Pubitemid 46233267)
7. The KIDS ART-LINC Collaboration. Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in sub-Saharan Africa. J Acquir Immune Defic Syndr 2008; 49(5):523-531.
8. Lallemant M, Jourdain G, Le Coeur S, et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med 2000; 343(14):982-991.
9. Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004; 351(3):217-228.
10. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infection. 1999. http://aidsinfo.nih.gov/ContentFiles/ PediatricGuidelines04051999024.pdf. Accessed 7 July 2009.
11. Thai Ministry of Public Health. National guidelines for the clinical management of HIV infection in children and adults. 2002. Bangkok, Thailand.
12. Chokephaibulkit K, Plipat N, Cressey TR, et al. Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine. AIDS 2005; 19(14): 1495-1499. (Pubitemid 41400695)
13. Puthanakit T, Oberdorfer A, Akarathum N, et al. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program. Clin Infect Dis 2005; 41(1):100-107. (Pubitemid 40863751)
14. Working Group on using Weight and Height References in Evaluating the Growth Status of Thai Children. Manual on using weight and height references in evaluating the growth status of Thai children. 2000. Department of Health, Ministry of Public Health, Bangkok, Thailand.
15. Traisathit P, et al., Effect of antiretroviral therapy on the growth of HIV infected children in Thailand. In: Program and abstracts of the 1st International Workshop on Pediatric HIV. 2009. Cape Town, South Africa.
16. Hess KR. Assessing time-by-covariate interactions in proportional hazards regression models using cubic spline functions. Stat Med 1994; 13:1045-1062.
17. Dunn D; HIV Paediatric Prognostic Markers Collaborative Study Group. Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. Lancet 2003; 362(9396):1605-1611.
18. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008; 359(21): 2233-2244.
19. van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 1999; 18:681-694.
20. Royston P. Multiple imputation of missing value. Stata J 2004; 4(3): 227-241.
21. US Census Bureau. International Database. 2010. http://www.census .gov/ipc/www/idb/country.php. Accessed 23 August 2010.
22. WHO. Mortality Country Fact Sheet: Thailand. 2006. http://www .who.int/whosis/mort/profiles/mort-searo-tha-thailand.pdf. Accessed 7 July 2009.
23. Fassinou P, Elenga N, Rouet F, et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote d'Ivoire. AIDS 2004; 18(14):1905-1913.
24. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA 2007; 298(16): 1888-1899.
25. Brady MT, Oleske JM, Williams PL, et al., Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era. J Acquir Immune Defic Syndr 2010; 53(1):86-94.
26. Judd A, Doerholt K, Tookey PA, et al. Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care. Clin Infect Dis 2007; 45(7):918-924.
27. Eley B, Davies MA, Apolles P, et al. Antiretroviral treatment for children. S Afr Med J 2006; 96(9 Pt 2):988-993.
28. Bong CN, Yu JK, Chiang HC, et al. Risk factors for early mortality in children on adult fixed-dose combination antiretroviral treatment in a central hospital in Malawi. AIDS 2007; 21(13):1805-1810.
29. Tovo PA, de Martino M, Gabiano C, et al. Prognostic factors and survival in children with perinatal HIV-1 infection. The Italian Register for HIV Infections in Children. Lancet 1992; 339(8804):1249-1253.
30. Taha TE, Kumwenda NI, Broadhead RL, et al. Mortality after the first year of life among human immunodeficiency virus type 1-infected and uninfected children. Pediatr Infect Dis J 1999; 18(8):689-694.
31. WHO. Report of the WHO Technical Reference Group Paediatric HIV/ ART Care Guideline Group Meeting. 2008. http://www.who.int/hiv/pub/paediatric/WHO- Paediatric-ART-guideline-rev-mreport-2008.pdf. Accessed 30 August 2008.
32. Sauvageot D, Schaefer M, Olson D, Pujades-Rodriguez M, O'Brien DP. Antiretroviral therapy outcomes in resource-limited settings for HIVinfected children <5 years of age. Pediatrics 2010; 125(5):e1039-e1047.
33. Goetghebuer T, Haelterman E, Le Chenadec J, et al; European Infant Collaboration group. Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. AIDS 2009; 23(5):597-604.
34. Creek T, Tanuri A, Smith M, et al. Early diagnosis of human immunodeficiency virus in infants using polymerase chain reaction on dried blood spots in Botswana's national program for prevention of mother-to- child transmission. Pediatr Infect Dis J 2008; 27(1):22-26.
35. Collins I, Ngo-Giang-Huong N, Leechanachai P, et al. Expanding access to early HIV diagnosis for infants in Thailand: from technology transfer to community outreach. In: Program and abstracts of the XVI International AIDS Conference. 2006. Toronto, Canada.
36. Ngo-Giang-Huong N, Khamduang W, Leurent B, et al. Early HIV-1 diagnosis using in-house real-time PCR amplification on dried blood spots for infants in remote and resource-limited settings. J Acquir Immune Defic Syndr 2008; 49(5):465-471.
37. Sundaram M, Lukhele B. Identification patient loss points from testing to treatment initiation among infants tested in Swaziland. In: Program and abstratcts of the 5th IAS Conference on HIV Pathogenesis Treatment and Prevention. 19-22 July 2009. Cape Town, South Africa.
38. UNAIDS. Children and AIDS: fourth stocktaking report, 2009. http://www.unicef.org/publications/files/Children-and-AIDS-Fourth-Stocktaking- Report-EN-120209.pdf. Accessed 10 February 2010.
39. McConnell M, Yuktanont P, Siangphoe U, et al. Survival rates following expansion of the national pediatric antiretroviral treatment program, Thailand, 2000-2005. In: Program and abstracts of the 5th IAS Conference on HIV Pathogenesis Treatment and Prevention. 19-22 July 2009. Cape Town, South Africa.
40. Rouet F, Fassinou P, Inwoley A, et al. Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens. AIDS 2006; 20(18):2315-2319. (Pubitemid 44789533)
41. Stover J, McKinnon R, Winfrey B. Spectrum: a model platform for linking maternal and child survival interventions with AIDS, family planning and demographic projections. Int J Epidemiol 2010; 39(Suppl 1):i7-i10.
42. Patel K, Hernán MA, Williams PL, et al. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis 2008; 46(4):507-515. (Pubitemid 351263487)
43. Brinkhof MW, Dabis F, Myer L, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ 2008; 86(7):559-567.